Clarivate Sees Unusually High Options Volume (NYSE:CLVT)

Clarivate PLC (NYSE:CLVT - Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors acquired 3,552 call options on the stock. This represents an increase of 1,544% compared to the average daily volume of 216 call options.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut Clarivate from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st.

Clarivate Stock Up 6.1%

Shares of NYSE CLVT traded up $0.26 during mid-day trading on Thursday, reaching $4.41. 10,791,692 shares of the company were exchanged, compared to its average volume of 5,300,863. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.90. The stock has a market cap of $3.01 billion, a price-to-earnings ratio of 6.38 and a beta of 1.47. Clarivate has a 1 year low of $3.04 and a 1 year high of $7.15. The firm has a 50-day moving average of $4.13 and a 200 day moving average of $4.47.

Clarivate (NYSE:CLVT - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. Clarivate had a positive return on equity of 8.75% and a negative net margin of 26.32%. The firm had revenue of $593.70 million for the quarter, compared to analyst estimates of $574.03 million. During the same period last year, the company earned $0.14 earnings per share. Clarivate's revenue for the quarter was down 4.4% compared to the same quarter last year. On average, research analysts expect that Clarivate will post 0.63 earnings per share for the current year.

Hedge Funds Weigh In On Clarivate

A number of institutional investors have recently added to or reduced their stakes in the stock. Clarkston Capital Partners LLC raised its holdings in shares of Clarivate by 5.4% in the 1st quarter. Clarkston Capital Partners LLC now owns 74,527,914 shares of the company's stock valued at $292,895,000 after buying an additional 3,794,083 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Clarivate by 53.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock worth $141,107,000 after buying an additional 9,691,104 shares in the last quarter. HG Vora Capital Management LLC purchased a new position in Clarivate in the 1st quarter valued at approximately $47,160,000. Thompson Siegel & Walmsley LLC grew its holdings in Clarivate by 14.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock valued at $53,333,000 after buying an additional 1,323,329 shares during the last quarter. Finally, AustralianSuper Pty Ltd acquired a new stake in shares of Clarivate during the first quarter worth $39,593,000. Hedge funds and other institutional investors own 85.72% of the company's stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.